Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Ranitidine and finasteride lower TMAO levels, reducing heart and kidney damage by changing gut bacteria.

"Flosin – Prostamol Uno" effectively manages BPH symptoms with fewer side effects.

Isotretinoin and acitretin may effectively stabilize the hairline in patients with frontal fibrosing alopecia.

TAGX-0003 protected hair follicles and reversed alopecia areata in a mouse model.

EVG staining helps tell apart follicular scars from follicular streamers, aiding in diagnosing different types of hair loss.

Blocking TGFβ can help treat fibrotic skin conditions by promoting fat cell formation.

Ezetimibe effectively reduces prostate size in cases of benign prostatic hyperplasia.

JAK inhibitors show promise in treating difficult skin diseases.

Tofacitinib is a promising and safe treatment for moderate to severe alopecia areata.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

Early diagnosis and treatment of frontal fibrosing alopecia are crucial to prevent permanent hair loss.

Platelet-rich fibrin helps heal stubborn wounds in rats by reducing inflammation and boosting tissue repair.

The combination of tadalafil and finasteride improves urinary symptoms and erectile function in men with enlarged prostates.

Blocking a certain signal in the gp130 receptor can improve tissue healing and lessen osteoarthritis symptoms.

Integrin β1 is crucial for liver structure and function, preventing fibrosis.

New compounds were made that effectively block a specific enzyme related to androgen conditions.

Prasugrel is better than clopidogrel at preventing heart damage and improving blood flow in small heart vessels during heart artery procedures.

The FN3-Alg hydrogel effectively heals irregular wounds and promotes hair growth.

Wedelolactone may help treat chronic diseases due to its strong antioxidant properties.

Teriflunomide is an effective and safe first-line oral treatment for relapsing multiple sclerosis.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

Baricitinib is effective and safe for treating severe alopecia areata.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

Baricitinib may effectively treat both alopecia areata and immune thrombocytopenia.

Micelles can change cetirizine's ionization, affecting its effectiveness in treatments.

Tofacitinib helped improve symptoms and hair growth in a patient with Aicardi-Goutières syndrome.

Early diagnosis and combination therapy, especially with finasteride and dutasteride, are key to managing Frontal Fibrosing Alopecia effectively.

Baricitinib might help treat hair loss in lupus patients, but more research is needed.